Regulators in Britain granted approval to the experimental drug molnupiravir from U.S. pharmaceutical giant Merck, marking the first authorization from a public health body for an oral antiviral treatment for covid-19 in adults.
Experts have said that if widely authorized, the medicine could have huge potential to help fight the coronavirus pandemic: Pills are easier to take, manufacture and store, making them particularly useful in lower- to middle-income countries with weaker infrastructure and limited vaccine supplies.
Source: Washington Post
https://www.washingtonpost.com/health/2021/11/04/covid19-pill-merck-molnupiravir-approval-uk/
